Steven R. Ph.D. Gullans Insider Trading $NRBO NeuroBo Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Steven R. Ph.D. Gullans.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steven R. Ph.D. Gullans. Steven R. Ph.D. Gullans is Director in TETRAPHASE PHARMACEUTICALS INC ($TTPH) and Director in Gemphire Therapeutics Inc. ($GEMP) and Interim President & CEO in Gemphire Therapeutics Inc. ($GEMP) and President & CEO in Gemphire Therapeutics Inc. ($GEMP).
Steven R. Ph.D. Gullans in NeuroBo Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Steven R. Ph.D. Gullans: Interim President & CEO, Director
Holdings: 300,000 shares
Current Value: $3,216,000
Latest Transaction: Jan 15 2020
$NRBO Market Capitalization: $97.34M
$NRBO Previous Close: $10.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Steven R. Ph.D. Gullans in NeuroBo Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 15 2020 | GEMP | NeuroBo Pharmaceut ... | Gullans Steven R. Ph.D. | Director | Option Exercise | A | 8.39 | 60,000 | 503,400 | 60,000 | |
| Jul 26 2019 | GEMP | Gemphire Therapeut ... | Gullans Steven R. Ph.D. | President & CEO | Grant | A | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
| May 24 2018 | GEMP | Gemphire Therapeut ... | Gullans Steven R. Ph.D. | President & CEO | Option Exercise | A | 5.56 | 50,000 | 278,000 | 50,000 | |
| May 24 2018 | GEMP | Gemphire Therapeut ... | Gullans Steven R. Ph.D. | President & CEO | Option Exercise | A | 5.56 | 50,000 | 278,000 | 50,000 | |
| Jan 30 2018 | GEMP | Gemphire Therapeut ... | Gullans Steven R. Ph.D. | Interim President & ... | Option Exercise | A | 10.44 | 60,000 | 626,400 | 60,000 | |
| May 31 2017 | GEMP | Gemphire Therapeut ... | Gullans Steven R. Ph.D. | Interim President & ... | Option Exercise | A | 10.26 | 60,000 | 615,600 | 60,000 | |
| Mar 14 2017 | GEMP | Gemphire Therapeut ... | Gullans Steven R. Ph.D. | Director | Option Exercise | P | 10.40 | 39,599 | 411,830 | 39,599 | |
| Mar 14 2017 | GEMP | Gemphire Therapeut ... | Gullans Steven R. Ph.D. | Director | Buy | P | 9.47 | 52,798 | 499,997 | 858,823 | 806 K to 858.8 K (+6.55 %) |
| Aug 12 2016 | GEMP | Gemphire Therapeut ... | Gullans Steven R. Ph.D. | Director | Buy | P | 10.00 | 500,000 | 5,000,000 | 806,025 | 306 K to 806 K (+163.39 %) |
| Aug 12 2016 | GEMP | Gemphire Therapeut ... | Gullans Steven R. Ph.D. | Director | Buy | C | 6.71 | 306,025 | 2,052,173 | 306,025 | 0 to 306 K |
| Aug 08 2016 | GEMP | Gemphire Therapeut ... | Gullans Steven R. Ph.D. | Director | Option Exercise | A | 10.00 | 60,000 | 600,000 | 60,000 |
Page: 1